日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Prochlorococcus marinus Trigger factor (tig) CSB-YP381360PZG
CSB-EP381360PZG
CSB-BP381360PZG
CSB-MP381360PZG
CSB-EP381360PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 50S ribosomal protein L20 (rplT) CSB-YP381361PZG
CSB-EP381361PZG
CSB-BP381361PZG
CSB-MP381361PZG
CSB-EP381361PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 50S ribosomal protein L9 (rplI) CSB-YP381362PZG
CSB-EP381362PZG
CSB-BP381362PZG
CSB-MP381362PZG
CSB-EP381362PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 30S ribosomal protein S6 (rpsF) CSB-YP381363PZG
CSB-EP381363PZG
CSB-BP381363PZG
CSB-MP381363PZG
CSB-EP381363PZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus UDP-N-acetylmuramate--L-alanine ligase (murC) CSB-YP381364PZH
CSB-EP381364PZH
CSB-BP381364PZH
CSB-MP381364PZH
CSB-EP381364PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Photosystem II reaction center X protein (psbX), partial CSB-YP381365PZH
CSB-EP381365PZH
CSB-BP381365PZH
CSB-MP381365PZH
CSB-EP381365PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus NAD (P)H-quinone oxidoreductase subunit O CSB-YP381366PZH
CSB-EP381366PZH
CSB-BP381366PZH
CSB-MP381366PZH
CSB-EP381366PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus NAD (P)H-quinone oxidoreductase subunit M CSB-YP381367PZH
CSB-EP381367PZH
CSB-BP381367PZH
CSB-MP381367PZH
CSB-EP381367PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP381368PZH
CSB-EP381368PZH
CSB-BP381368PZH
CSB-MP381368PZH
CSB-EP381368PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 1,4-dihydroxy-2-naphthoyl-CoA hydrolase (NATL1_02481) CSB-YP381369PZH
CSB-EP381369PZH
CSB-BP381369PZH
CSB-MP381369PZH
CSB-EP381369PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Ribonuclease H (rnhA) CSB-YP381370PZH
CSB-EP381370PZH
CSB-BP381370PZH
CSB-MP381370PZH
CSB-EP381370PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 50S ribosomal protein L10 (rplJ) CSB-YP381371PZH
CSB-EP381371PZH
CSB-BP381371PZH
CSB-MP381371PZH
CSB-EP381371PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Enolase (eno) CSB-YP381372PZH
CSB-EP381372PZH
CSB-BP381372PZH
CSB-MP381372PZH
CSB-EP381372PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Chorismate synthase (aroC) CSB-YP381373PZH
CSB-EP381373PZH
CSB-BP381373PZH
CSB-MP381373PZH
CSB-EP381373PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Photosystem II reaction center protein I (psbI), partial CSB-YP381374PZH
CSB-EP381374PZH
CSB-BP381374PZH
CSB-MP381374PZH
CSB-EP381374PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 3-isopropylmalate dehydratase large subunit (leuC) CSB-YP381375PZH
CSB-EP381375PZH
CSB-BP381375PZH
CSB-MP381375PZH
CSB-EP381375PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Sugar fermentation stimulation protein homolog (sfsA) CSB-YP381376PZH
CSB-EP381376PZH
CSB-BP381376PZH
CSB-MP381376PZH
CSB-EP381376PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Non-canonical purine NTP pyrophosphatase (NATL1_03591) CSB-YP381377PZH
CSB-EP381377PZH
CSB-BP381377PZH
CSB-MP381377PZH
CSB-EP381377PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Photosystem II reaction center protein L (psbL), partial CSB-YP381378PZH
CSB-EP381378PZH
CSB-BP381378PZH
CSB-MP381378PZH
CSB-EP381378PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus S-adenosylmethionine synthase (metK) CSB-YP381379PZH
CSB-EP381379PZH
CSB-BP381379PZH
CSB-MP381379PZH
CSB-EP381379PZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×